Medicine and Dentistry
Ulcerative Colitis
96%
Inflammatory Bowel Disease
93%
Neoplasm
90%
Colonoscopy
84%
Prevalence
65%
Stomach Cancer
58%
Diagnosis
56%
Odds Ratio
54%
Disease
54%
Adenoma
53%
Patient with Crohn's Disease
50%
Crohn's Disease
48%
Patient with Inflammatory Bowel Disease
48%
Colitis
41%
Reflux Esophagitis
40%
Lymph Node Metastasis
39%
Symptom
38%
Hazard Ratio
37%
Colon
37%
Tumor Necrosis Factor
37%
Polypectomy
37%
Pelvic Floor
31%
Helicobacter Pylori
31%
Surgery
31%
Endoscopic Submucosal Dissection
30%
Bleeding
29%
Colorectal Cancer
28%
Adverse Event
28%
Recurrent Disease
27%
Cohort Analysis
27%
Mesenchymal Stem Cell
26%
Tonsil
26%
Endoscopy
25%
Polyp
25%
Infliximab
25%
Intestine Preparation
23%
Ultrasonography
23%
Clinical Feature
23%
Prospective Study
22%
Colorectal Tumor
22%
Prospective Cohort Study
21%
Microscopic Colitis
21%
Predictive Factor
21%
TNF Inhibitor
20%
Computer Assisted Tomography
20%
Patient with Ulcerative Colitis
19%
Peptoclostridium difficile
19%
Colon Polyp
18%
Fluorodeoxyglucose F 18
18%
Anal Canal
18%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Ulcerative Colitis
94%
Crohn's Disease
56%
Prevalence
53%
Tumor Necrosis Factor
42%
Colitis
41%
Disease
37%
Helicobacter Pylori
36%
Adenoma
35%
Bleeding
34%
Stomach Cancer
30%
Dextran Sulfate
26%
Adverse Event
24%
Prospective Study
22%
Neoplasm
22%
Clinical Feature
21%
Disease Activity
20%
Mouse
20%
Jejunum Ulcer
19%
Reflux Esophagitis
18%
Remission
17%
Infliximab
17%
Ascorbic Acid
17%
Prospective Cohort Study
17%
Colon Adenoma
17%
Macrogol
17%
Adiponectin
17%
Colorectal Cancer
15%
Cytokine
15%
Symptom
15%
Malignant Neoplasm
15%
Combination Therapy
14%
Recurrent Disease
14%
Polyp
14%
Enteropathy
14%
Mercaptopurine
13%
Murine
13%
Colon Cancer
13%
Vasculotropin
13%
Cytomegalovirus Infection
13%
Omeprazole
13%
Interferon
13%
Antibiotic Associated Diarrhea
13%
Gelatinase A
12%
Vaccination Policy
12%
Fibrosis
12%
Tumor Necrosis Factor Inhibitor
11%
Normal Human
11%
Inflammation
11%
Dyspepsia
11%
Immunology and Microbiology
Inflammatory Bowel Disease
62%
Ulcerative Colitis
49%
Crohn's Disease
43%
Colitis
40%
Mesenchymal Stem Cell
39%
Tonsil
39%
Interferon Type I
26%
Colon
25%
Esophagitis
21%
Tumor Necrosis Factor
19%
Angiogenesis
17%
Prevalence
13%
Murine
13%
Peptoclostridium difficile
13%
Cytomegalovirus Infection
13%
Adiponectin
13%
Hepatitis B Virus
12%
Cancer Cell
11%
Mouse
11%
Vasculotropin
11%
Cytomegalovirus
11%
Vaccination Policy
11%
Hepatitis B
10%
Body Mass
10%
T Cell
10%
Interleukin 17
9%
Helicobacter Pylori
9%
Enteritis
9%
Inflammation Response
8%
Carcinogenic Activity
8%
DNA Virus
8%
Asthma
8%
Endoplasmic Reticulum Stress
8%
Ozanimod
8%
Knockout Mouse
8%
Hypoxia Inducible Factor 1alpha
8%
Anti-Saccharomyces Cerevisiae Antibody
8%
Lactobacillus paracasei
8%
T Cell Receptor
8%
Hepatitis B Vaccination
8%
Bacterial Population
8%
Infectious Agent
8%
Strain Identification
8%
Staphylococcus Haemolyticus
8%
Cross-Resistance
8%
Microscopic Colitis
8%
Integrin
8%
Staphylococcus Epidermidis
8%
Tumor Necrosis Factor Alpha
8%
Interleukin 8
8%